Computer simulations reveal that the NFGAILSS peptide inhibits hIAPP fibrillation in type 2 diabetes, suggesting a potential therapeutic approach.
The fibrillation of human islet amyloid polypeptide (hIAPP) to cytotoxic oligomer species and amyloid fibrils is a significant pathological factor in type 2 diabetes (T2D). Thus, targeting hIAPP fibrillation offers...
No takes yet. Share an insight, caveat, or question.
Mehta et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: